DECA Dental Group chose Pearl to be its only provider of dental AI solutions. This partnership brings the most up-to-date technology to clinics in nine states. Pearl’s platform lets doctors quickly find diseases in dental X-rays. In addition, a pilot study found that AI-visualized radiographs greatly increase the likelihood of case acceptance. Because of this, the organization expects to get a good return on investment because the diagnosis will be clearer.
Pearl’s FDA-approved technology works directly with practice management software that is already in use. So, doctors don’t have to switch platforms during busy workdays. The system puts the results straight into clinical records. Because of this, teams can keep up high standards of care without changing their daily routines. This integration also gives the whole organization visibility across the whole enterprise.
“As a clinician-led organization, our responsibility is to listen to our doctors’ needs and ensure they have the best tools on the market to unlock confident, consistent diagnoses. We all know clinicians’ days are incredibly busy, and so easing the barrier to technology adoption is essential. Pearl is embedded in DECA’s practice management system, meaning it accompanies our clinicians throughout their days, in their existing workflows, and in their current platforms of choice,” said Dr. Matthew Doan, Vice President of Clinical Training and Development at DECA Dental Group. “Each of our clinicians cares deeply about clinical excellence, and Pearl allows us to support their goals while preserving clinical autonomy, helping our teams deliver better outcomes for patients every day. We know having always-on AI insights at their fingertips is going to be a huge help as clinicians go about their days, and we’re excited to deploy Pearl organization-wide.”
The software fills in the gaps between diagnosis and care. In particular, it turns small discoveries into easy-to-understand visuals for patients. Patients now have a better understanding of what they need for treatment. Pearl is currently allowed to do business in 120 countries.
“When DSOs evaluate AI today, the question is no longer whether it can benefit their clinicians, practices, and patients. The question today is, how well does AI fit into the reality of clinical practices at scale?” said Ophir Tanz, Founder and CEO of Pearl. “DECA’s decision to deploy Pearl reflects a thoughtful approach to adoption. By bringing AI insights directly into the clinical environment through the existing PMS, teams can make better decisions, maintain visibility across locations, and trust AI as a dependable part of everyday care rather than a separate tool clinicians have to add to their workflows.”
This partnership shows a shared dedication to high-quality clinical care. DECA is now the leader in the field by using AI to give clinicians more freedom. Also, the technology makes sure that patients get the same care at all locations. Lastly, Pearl is still changing the way people around the world experience dental care by coming up with new ideas all the time.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
